Mumbai, Sept. 15 -- ZyVet(R) Animal Health, a leader in affordable generic pharmaceuticals for animals, a wholly owned subsidiary of Zydus Pharmaceuticals (USA) Inc., itself a wholly owned subsidiary of Zydus Lifesciences, a global innovation led healthcare company, has released the first FDA-approved generic of phenylpropanolamine hydrochloride tablets, a trusted treatment for managing urinary incontinence in dogs. This latest product underscores ZyVet's mission to bring trusted, high-quality, and cost-effective therapies to veterinary professionals across the United States.

Published by HT Digital Content Services with permission from Capital Market....